Physician profile
Stephen Kwan
NPI 1518052356
$1,180.48
in general payments reported to CMS, 2019-2025
8 companies · $27.29 in 2025
The $27.29 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $111 · 2021: $78.64 · 2022: $366 · 2023: $260 · 2024: $14.99 · 2025: $27.29.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $301.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $465.81 | 2021-2023 | Mosaic, Penditure, Avalus |
| Abbott Laboratories | $225.84 | 2019-2020 | |
| Edwards Lifesciences Corporation | $204.16 | 2022-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Livanova USA, INC. | $126.60 | 2019 | |
| Atricure, INC. | $109.04 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2) |
| Corcym INC | $20.97 | 2023 | Perceval |
| E.R. Squibb & Sons, L.L.C. | $14.99 | 2024 | Eliquis |
| Boston Scientific Corporation | $13.07 | 2023 | Bodyguardian |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kwan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.